NCT06822712View on ClinicalTrials.gov

Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for De Novo Coronary Bifurcation Lesions

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

March 3, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
Coronary Arterial Disease (CAD)
Interventions
DEVICE

Sirolimus-coated Balloon Dilatation Catheter

During PCI, percutaneous transluminal coronary angioplasty is performed on the target lesion using the Sirolimus-coated Balloon Dilatation Catheter in the test group, subsequently completing the remaining procedure

DEVICE

Paclitaxel-coated Balloon Dilatation Catheter

During PCI, percutaneous transluminal coronary angioplasty is performed on the target lesion using the Paclitaxel-coated Balloon Dilatation Catheter in the control group, subsequently completing the remaining procedure

Trial Locations (1)

Unknown

RECRUITING

The First Hospital of Lanzhou University, Lanzhou

All Listed Sponsors
collaborator

First Affiliated Hospital of Lanzhou University

UNKNOWN

lead

BrosMed Medical Co., Ltd

INDUSTRY